¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ 19Â÷ Çмú´ëȸ : 2019-11-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ 19Â÷ Çмú´ëȸ : 2019-11-08
±³À°ÀÏÀÚ : 2019-11-08
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ, ±×·£µåº¼·ë ÇѶó(3F)  
±³À°ÁÖÁ¦ : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ 19Â÷ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ  
´ã´çÀÚ : À¯¹Ú¸°
¿¬¶ôó : 02-440-7329  
À̸ÞÀÏ : kda@derma.or.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 300,000¿ø      
ºñ°í È¸¿ø »çÀü:40,000¿ø,ÇöÀå 50,000¿ø / ºñȸ¿ø »çÀü 200,000¿ø, ÇöÀå 300,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-08 ±×·£µåº¼·ë ÇѶó 13:40~14:05 Consensus guideline for the diagnosis of severe atopic dermatitis  À̾ç¿ø(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 11-08 ±×·£µåº¼·ë ÇѶó 14:05~14:30 Expert consensus on the systemic treatment of moderate to severe atopic dermatitis  ³ëÁÖ¿µ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-08 ±×·£µåº¼·ë ÇѶó 14:30~15:20 Atopic dermatitis: "A heterogenous disorder"  Jonathan Silvergerg(Northwestern university) 
±³À°½Ã°£ 11-08 ±×·£µåº¼·ë ÇѶó 15:20~16:00 Real-world experience of Japanese patients on dupilumab  Masahiro Kamata(Teikyo university) 
±³À°½Ã°£ 11-08 ±×·£µåº¼·ë ÇѶó 16:20~17:10 Clinical management of the patient with moderate-to-severe atopic dermatitis  Thomas Bieber(Bonn university) 
±³À°½Ã°£ 11-08 ±×·£µåº¼·ë ÇѶó 17:10~17:50 The efficacy and role of alitretinoin on atopic dermatitis  Thomas Ruzicka(Ludwig-Maximilian university) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ 19Â÷ Çмú´ëȸ : 2019-11-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѼºÇü¿Ü°úÇÐȸ PRS KOREA 2019 : 2019-11-08
´ÙÀ½±Û ¼­¿ï¼º¸ðº´¿ø Çù·Âº´¿øÀåÀ» À§ÇÑ ±âµµ°ü¸® ¹× ¼Ò»ý¼ú ÈƷðúÁ¤ : 2019-11-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
92 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-24 0 306 2018-07-28
91 ¼­¿ï 2018³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãß°èÇмú´ëȸ(8/24) : 2018-08-24 0 324 2018-07-28
90 ÀÎõ °­È­±ºÀÇ»çȸ 3Â÷ ¼¼¹Ì³ª(°üÀýº¸Á¸ Ä¡·á) : 2018-08-24 0 326 2018-07-28
89 °æ±â Á¦5Â÷ ¾Æ½Ã¾ÆºÎÀÎÁ¾¾çÇÐȸ ¿öÅ©¼ó(ASGO 5th International Workshop on Gynecologic Oncology in conjunction with 12th KSGO Workshop for Young Gynecologic Oncologists) : 2018-08-24 0 483 2018-07-28
88 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè°ú ¹Î°£ÀǷẸÇè : 2018-08-23 0 296 2018-07-28
87 ¼­¿ï ±¹¸³ÀÇ·á¿ø 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-23 0 368 2018-07-28
86 ¼­¿ï ±¹¸³ÀÇ·á¿ø 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ±³À°[»çÀüµî·Ï Çʼö] : 2018-08-22 0 475 2018-07-28
85 ¼­¿ï ´ëÇÑÀÓ»óÅëÁõÇÐȸ 2018³â Á¦2ȸ Á¤±âÇмúÁý´ãȸ : 2018-08-22 0 439 2018-07-28
84 °æºÏ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ ´ë±¸°æºÏÁöȸ Á¦4Â÷ Áõ·ÊÅä·Ðȸ : 2018-08-21 0 421 2018-07-28
83 Ãæ³² ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ´ëÀüÃæûÁöȸ 8¿ù ¿¬¼ö°­Á : 2018-08-21 0 381 2018-07-28
82 °­¿ø ±¹¸³ÀÇ·á¿ø °ø°øÀÇ·á Consensus conference(3Â÷: °­¿ø±Ç) : 2018-08-20 0 437 2018-07-28
81 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ ¾à¹°Ä¡·á ¿¬¼ö°­Á : 2018-08-19 0 485 2018-07-28
80 ¼­¿ï Á¦16ȸ ±è¾È°úº´¿ø ½ÉÆ÷Áö¾ö : 2018-08-19 1 778 2018-07-28
79 ¼­¿ï 2018 ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ °³¿ø¼¼¹Ì³ª : 2018-08-19 0 697 2018-07-28
78 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦7ȸ ¿°Áõ¼º ÀåÁúȯ ¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-08-19 0 335 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷